Dynavax Statistics
Share Statistics
Dynavax has 120.08M
shares outstanding. The number of shares has increased by -5.21%
in one year.
| Shares Outstanding | 120.08M |
| Shares Change (YoY) | -5.21% |
| Shares Change (QoQ) | -5.62% |
| Owned by Institutions (%) | 99.55% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 36 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 19.61M, so 16.33% of the outstanding
shares have been sold short.
| Short Interest | 19.61M |
| Short % of Shares Out | 16.33% |
| Short % of Float | 24.31% |
| Short Ratio (days to cover) | 8.26 |
Valuation Ratios
The PE ratio is 60.81 and the forward
PE ratio is 18.51.
Dynavax's PEG ratio is
-0.12.
| PE Ratio | 60.81 |
| Forward PE | 18.51 |
| PS Ratio | 5.99 |
| Forward PS | 2.1 |
| PB Ratio | 2.78 |
| P/FCF Ratio | 27.6 |
| PEG Ratio | -0.12 |
Financial Ratio HistoryEnterprise Valuation
Dynavax has an Enterprise Value (EV) of 1.82B.
| EV / Sales | 6.56 |
| EV / EBITDA | 39.81 |
| EV / EBIT | 27.35 |
| EV / FCF | 30.24 |
Financial Position
The company has a current ratio of 10.8,
with a Debt / Equity ratio of 0.43.
| Current Ratio | 10.8 |
| Quick Ratio | 9.91 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 5.57 |
| Debt / FCF | 4.23 |
| Interest Coverage | -0.61 |
Financial Efficiency
Return on Equity is 4.58% and Return on Invested Capital is -0.4%.
| Return on Equity | 4.58% |
| Return on Assets | 2.77% |
| Return on Invested Capital | -0.4% |
| Revenue Per Employee | $684,558.02 |
| Profits Per Employee | $67,429.63 |
| Employee Count | 405 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 0.71 |
Taxes
| Income Tax | 3.55M |
| Effective Tax Rate | 11.49% |
Stock Price Statistics
The stock price has increased by -13.87% in the
last 52 weeks. The beta is 1.26, so Dynavax's
price volatility has been higher than the market average.
| Beta | 1.26 |
| 52-Week Price Change | -13.87% |
| 50-Day Moving Average | 11.55 |
| 200-Day Moving Average | 12.02 |
| Relative Strength Index (RSI) | 40.15 |
| Average Volume (20 Days) | 2,673,700 |
Income Statement
In the last 12 months, Dynavax had revenue of 277.25M
and earned 27.31M
in profits. Earnings per share was 0.21.
| Revenue | 277.25M |
| Gross Profit | 227.8M |
| Operating Income | -4.12M |
| Net Income | 27.31M |
| EBITDA | 45.7M |
| EBIT | 37.65M |
| Earnings Per Share (EPS) | 0.21 |
Full Income StatementBalance Sheet
The company has 95.88M in cash and 254.42M in
debt, giving a net cash position of -158.53M.
| Cash & Cash Equivalents | 95.88M |
| Total Debt | 254.42M |
| Net Cash | -158.53M |
| Retained Earnings | -903.27M |
| Total Assets | 945.93M |
| Working Capital | 747.59M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 66.51M
and capital expenditures -6.35M, giving a free cash flow of 60.16M.
| Operating Cash Flow | 66.51M |
| Capital Expenditures | -6.35M |
| Free Cash Flow | 60.16M |
| FCF Per Share | 0.46 |
Full Cash Flow StatementMargins
Gross margin is 82.17%, with operating and profit margins of -1.49% and 9.85%.
| Gross Margin | 82.17% |
| Operating Margin | -1.49% |
| Pretax Margin | 11.13% |
| Profit Margin | 9.85% |
| EBITDA Margin | 16.48% |
| EBIT Margin | -1.49% |
| FCF Margin | 21.7% |
